Clinical manifestations in patients with primary Sjögren’s syndrome, with and without p19 or tax antibody in the salivary glands.
| p19 | tax | p19 or tax | ||||
|---|---|---|---|---|---|---|
| Manifestations | Positive, n = 10 | Negative, n = 23 | Positive, n = 10 | Negative, n = 23 | Positive, n = 14 | Negative, n = 19 |
| Glandular (%) | ||||||
| Dryness of eyes | 9/10 (90) | 23/23 (100) | 9/10 (90) | 23/23 (100) | 13/14 (92.9) | 19/19 (100) |
| Dryness of mouth | 9/10 (90) | 23/23 (100) | 9/10 (90) | 23/23 (100) | 13/14 (92.9) | 19/19 (100) |
| Parotid gland enlargement | 2/10 (20) | 4/23 (17.4) | 1/10 (10) | 5/23 (21.7) | 2/14 (14.3) | 4/19 (21.1) |
| Extraglandular (%) | ||||||
| Joint pain | 6/10 (60) | 16/23 (69.6) | 6/10 (60) | 16/23 (69.6) | 9/14 (64.3) | 13/19 (68.4) |
| Raynaud’s phenomenon | 4/10 (40) | 10/23 (43.5) | 4/10 (40) | 10/23 (43.5) | 7/14 (50) | 7/19 (36.8) |
| Photosensitivity | 2/10 (20) | 4/23 (17.4) | 1/10 (10) | 5/23 (21.7) | 2/14 (14.3) | 4/19 (21.1) |
| Peripheral neuropathy | 3/10 (30) | 3/23 (13) | 3/10 (30) | 3/23 (13) | 4/14 (28.6) | 2/19 (10.5) |
| Lymphadenopathy | 0/10 (0) | 6/23 (26.1) | 0/10 (0) | 6/23 (26.1) | 0/14 (0) | 6/19 (31.6) |
| Interstitial lung disease | 1/10 (10) | 3/23 (13) | 0/10 (0) | 4/23 (17.4) | 1/14 (7.1) | 3/19 (15.8) |
| Renal tubular acidosis | 1/10 (10) | 2/23 (8.7) | 1/10 (10) | 2/23 (8.7) | 1/14 (7.1) | 2/19 (10.5) |
| Autoimmune thyroid disease | 2/10 (20) | 1/23 (4.3) | 1/10 (10) | 2/23 (8.7) | 2/14 (14.3) | 1/19 (5.3) |
| Psychosis | 1/10 (10) | 0/23 (0) | 1/10 (10) | 0/23 (0) | 1/14 (7.1) | 0/19 (0) |